{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:04:19Z","timestamp":1788577459842,"version":"build-2803163510"},"reference-count":118,"publisher":"Bioscientifica","issue":"10","content-domain":{"domain":["erc.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7,10]]},"abstract":"<jats:p>The relationship between growth hormone (GH) excess and cancer is a controversial matter. Until 2016, most studies in patients with acromegaly found links with colon and thyroid neoplasms. However, recent studies found increased risks in gastric, breast, and urinary tract cancer also. Concordantly, clinical situations where GH and insulin-like growth facto-I deficits exist are indeed associated with diminished malignancy incidence. In line with these observations, gain-of-function mutations of various enzymes belonging to the GH and IGF-I signaling pathways have been associated with increased carcinogenesis; similarly, loss-of-function mutations of other enzymes that usually work as tumor repressors are also associated with augmented cancer risk. In a study performed in Ecuador, it was demonstrated that subjects in the Ecuadorian cohort with Laron syndrome (ELS), who have a mutant GH receptor and greatly diminished GH and IGF-I signaling, display diminished incidence of cancer. Along with absent action of GH and IGF-I, ELS individuals also have low serum insulin levels and decreased insulin resistance. Furthermore, hyperglycemia and hyperinsulinemia are indispensable for fast cell mitosis, including that of those cells present in the benign and malignant neoplasms. Notably, and despite their obesity, subjects with the ELS display normoglycemia and hypo-insulinemia, along with diminished incidence of malignancies. We believe that the dual low-IGF-I\/low insulin serum levels are responsible for the cancer protection, especially considering that the insulin\/INSR signaling is a central site for energy generation in the form of ATP and GDP, which are indispensable for all and every GH\/IGF-I physiologic as well as pathologic events.<\/jats:p>","DOI":"10.1530\/erc-22-0402","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T12:52:44Z","timestamp":1688993564000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":23,"title":["Cancer in growth hormone excess and growth hormone deficit"],"prefix":"10.1530","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9298-6484","authenticated-orcid":true,"given":"Jaime","family":"Guevara-Aguirre","sequence":"first","affiliation":[{"name":"Colegio de Ciencias de la Salud, Universidad San Francisco de Quito, Diego de Robles s\/n y Pampite, Cumbay\u00e1, Quito, Ecuador"},{"name":"Instituto de Endocrinolog\u00eda IEMYR, Quito, Ecuador"},{"name":"Maastricht University, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Pe\u00f1a","sequence":"additional","affiliation":[{"name":"Colegio de Ciencias de la Salud, Universidad San Francisco de Quito, Diego de Robles s\/n y Pampite, Cumbay\u00e1, Quito, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Acosta","sequence":"additional","affiliation":[{"name":"Colegio de Ciencias de la Salud, Universidad San Francisco de Quito, Diego de Robles s\/n y Pampite, Cumbay\u00e1, Quito, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Pazmi\u00f1o","sequence":"additional","affiliation":[{"name":"Colegio de Ciencias de la Salud, Universidad San Francisco de Quito, Diego de Robles s\/n y Pampite, Cumbay\u00e1, Quito, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannette","family":"Saavedra","sequence":"additional","affiliation":[{"name":"Instituto de Endocrinolog\u00eda IEMYR, Quito, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Soto","sequence":"additional","affiliation":[{"name":"Colegio de Ciencias de la Salud, Universidad San Francisco de Quito, Diego de Robles s\/n y Pampite, Cumbay\u00e1, Quito, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Lescano","sequence":"additional","affiliation":[{"name":"Colegio de Ciencias de la Salud, Universidad San Francisco de Quito, Diego de Robles s\/n y Pampite, Cumbay\u00e1, Quito, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Guevara","sequence":"additional","affiliation":[{"name":"Instituto de Endocrinolog\u00eda IEMYR, Quito, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio W D","family":"Gavilanes","sequence":"additional","affiliation":[{"name":"Maastricht University, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"Applied Physiology, Nutrition, and Metabolism","first-page":"395","article-title":"mTORC1 and the regulation of skeletal muscle anabolism and mass","volume":"37","author":"Adegoke","year":"2012","unstructured":"Adegoke OAJAbdullahi A & Tavajohi-Fini P2012mTORC1 and the regulation of skeletal muscle anabolism and mass. Applied Physiology, Nutrition, and Metabolism37395\u2013406. (https:\/\/doi.org\/10.1139\/h2012-009)"},{"key":"bib2","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"714","article-title":"Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene","volume":"95","author":"Aguiar-Oliveira","year":"2010","unstructured":"Aguiar-Oliveira MHOliveira FTPereira RMCOliveira CRPBlackford AValenca EHOSantos EGGois-Junior MBMeneguz-Moreno RAAraujo VP, 2010Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene. Journal of Clinical Endocrinology and Metabolism95714\u2013721. (https:\/\/doi.org\/10.1210\/jc.2009-1879)"},{"key":"bib3","series-title":"European Journal of Endocrinology","first-page":"R85","article-title":"Mechanisms In Endocrinology: the multiple facets of GHRH\/GH\/IGF-I axis: lessons from lifetime, untreated, isolated GH deficiency due to a GHRH receptor gene mutation","volume":"177","author":"Aguiar-Oliveira","year":"2017","unstructured":"Aguiar-Oliveira MHSouza AHOOliveira CRPCampos VCOliveira-Neto LA & Salvatori R2017Mechanisms In Endocrinology: the multiple facets of GHRH\/GH\/IGF-I axis: lessons from lifetime, untreated, isolated GH deficiency due to a GHRH receptor gene mutation. European Journal of Endocrinology177R85\u2013R97. (https:\/\/doi.org\/10.1530\/EJE-16-1047)"},{"key":"bib4","series-title":"Cancer Medicine","first-page":"1307","article-title":"Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories","volume":"5","author":"Arthur","year":"2016","unstructured":"Arthur RM\u00f8ller HGarmo HHolmberg LStattin PMalmstrom HLambe MHammar NWalldius GRobinson D, 2016Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories. Cancer Medicine51307\u20131318. (https:\/\/doi.org\/10.1002\/cam4.665)"},{"key":"bib5","series-title":"Human Mutation","first-page":"24","article-title":"Mutation creating a new splice site in the growth hormone receptor genes of 37 Ecuadorean patients with Laron syndrome","volume":"1","author":"Berg","year":"1992","unstructured":"Berg MAGuevara-Aguirre JRosenbloom ALRosenfeld RG & Francke U1992Mutation creating a new splice site in the growth hormone receptor genes of 37 Ecuadorean patients with Laron syndrome. Human Mutation124\u201332. (https:\/\/doi.org\/10.1002\/humu.1380010105)"},{"key":"bib6","series-title":"American Journal of Human Genetics","first-page":"998","article-title":"Diverse growth hormone receptor gene mutations in Laron syndrome","volume":"52","author":"Berg","year":"1993","unstructured":"Berg MAArgente JChernausek SGracia RGuevara-Aguirre JHopp MP\u00e9rez-Jurado LRosenbloom AToledo SP & Francke U1993Diverse growth hormone receptor gene mutations in Laron syndrome. American Journal of Human Genetics52998\u20131005."},{"key":"bib7","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"2493","article-title":"Short stature caused by a biologically inactive mutant growth hormone (GH-C53S)","volume":"90","author":"Besson","year":"2005","unstructured":"Besson ASalemi SDelado\u00eby JVuissoz JMEbl\u00e9 ABidlingmaier MB\u00fcrgi SHonegger UFl\u00fcck C & Mullis PE2005Short stature caused by a biologically inactive mutant growth hormone (GH-C53S). Journal of Clinical Endocrinology and Metabolism902493\u20132499. (https:\/\/doi.org\/10.1210\/jc.2004-1838)"},{"key":"bib8","series-title":"Nature","first-page":"108","article-title":"Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides","volume":"508","author":"Birsoy","year":"2014","unstructured":"Birsoy KPossemato RLorbeer FKBayraktar ECThiru PYucel BWang TChen WWClish CB & Sabatini DM2014Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides. Nature508108\u2013112. (https:\/\/doi.org\/10.1038\/nature13110)"},{"key":"bib9","series-title":"European Journal of Endocrinology","first-page":"R147","article-title":"Management of Endocrine disease: acromegaly and cancer: an old debate revisited","volume":"175","author":"Boguszewski","year":"2016","unstructured":"Boguszewski CL & Ayuk J2016Management of Endocrine disease: acromegaly and cancer: an old debate revisited. European Journal of Endocrinology175R147\u2013R156. (https:\/\/doi.org\/10.1530\/EJE-16-0178)"},{"key":"bib10","series-title":"Endocrine Reviews","first-page":"558","article-title":"Growth hormone\u2019s links to cancer","volume":"40","author":"Boguszewski","year":"2019","unstructured":"Boguszewski CL & Boguszewski MCDS2019Growth hormone\u2019s links to cancer. Endocrine Reviews40558\u2013574. (https:\/\/doi.org\/10.1210\/er.2018-00166)"},{"key":"bib11","series-title":"Pituitary","first-page":"810","article-title":"Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors-a review of research and clinical practice","volume":"24","author":"Boguszewski","year":"2021","unstructured":"Boguszewski MCSCardoso-Demartini AABoguszewski CLChemaitilly WHigham CEJohannsson G & Yuen KCJ2021Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors-a review of research and clinical practice. Pituitary24810\u2013827. (https:\/\/doi.org\/10.1007\/s11102-021-01173-0)"},{"key":"bib12","series-title":"European Journal of Endocrinology","first-page":"59","article-title":"Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis","volume":"179","author":"Bolfi","year":"2018","unstructured":"Bolfi FNeves AFBoguszewski CL & Nunes-Nogueira VS2018Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis. European Journal of Endocrinology17959\u201371. (https:\/\/doi.org\/10.1530\/EJE-18-0255)"},{"key":"bib13","series-title":"Nature Reviews. Endocrinology","first-page":"515","article-title":"The growth hormone receptor: mechanism of activation and clinical implications","volume":"6","author":"Brooks","year":"2010","unstructured":"Brooks AJ & Waters MJ2010The growth hormone receptor: mechanism of activation and clinical implications. Nature Reviews. Endocrinology6515\u2013525. (https:\/\/doi.org\/10.1038\/nrendo.2010.123)"},{"key":"bib14","series-title":"Experimental Cell Research","first-page":"281","article-title":"Tetracyclines cause cell stress-dependent ATF4 activation and mTOR inhibition","volume":"320","author":"Br\u00fcning","year":"2014","unstructured":"Br\u00fcning ABrem GJVogel M & Mylonas I2014Tetracyclines cause cell stress-dependent ATF4 activation and mTOR inhibition. Experimental Cell Research320281\u2013289. (https:\/\/doi.org\/10.1016\/j.yexcr.2013.11.012)"},{"key":"bib15","series-title":"Clinical Dysmorphology","first-page":"218","article-title":"X-linked isolated growth hormone deficiency: expanding the phenotypic spectrum of SOX3 polyalanine tract expansions","volume":"18","author":"Burkitt Wright","year":"2009","unstructured":"Burkitt Wright EMMPerveen RClayton PEHall CMCosta TProcter AMGiblin CADonnai D & Black GC2009X-linked isolated growth hormone deficiency: expanding the phenotypic spectrum of SOX3 polyalanine tract expansions. Clinical Dysmorphology18218\u2013221. (https:\/\/doi.org\/10.1097\/MCD.0b013e32832d06f0)"},{"key":"bib16","series-title":"Growth Hormone and IGF Research","first-page":"11","article-title":"Growth hormone signaling pathways","volume":"28","author":"Carter-Su","year":"2016","unstructured":"Carter-Su CSchwartz J & Argetsinger LS2016Growth hormone signaling pathways. Growth Hormone and IGF Research2811\u201315. (https:\/\/doi.org\/10.1016\/j.ghir.2015.09.002)"},{"key":"bib17","series-title":"GeneReviews","article-title":"2000 PROP1-related combined pituitary hormone deficiency","author":"Carvalho","unstructured":"Carvalho LRNishi MYCorrea FAMoreira Marques JArnhold IJP & Mendonca BB2000 PROP1-related combined pituitary hormone deficiency. In GeneReviews. Seattle,WA, USA: University of Washington. (available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1347\/)"},{"key":"bib18","series-title":"Growth Hormone Deficiency","first-page":"177","article-title":"Combined pituitary hormone deficiency","author":"Castinetti","year":"2016","unstructured":"Castinetti F & Brue T2016Combined pituitary hormone deficiency. In Growth Hormone Deficiency. CohenLE Ed. Cham: Springer International Publishing, pp. 177\u2013194. (https:\/\/doi.org\/10.1007\/978-3-319-28038-7_12)"},{"key":"bib19","series-title":"Expert Review of Endocrinology and Metabolism","first-page":"71","article-title":"Role of the growth hormone-IGF-1 axis in cancer","volume":"6","author":"Chhabra","year":"2011","unstructured":"Chhabra YWaters MJ & Brooks AJ2011Role of the growth hormone-IGF-1 axis in cancer. Expert Review of Endocrinology and Metabolism671\u201384. (https:\/\/doi.org\/10.1586\/eem.10.73)"},{"key":"bib20","series-title":"Molecular Cancer Research","first-page":"1156","article-title":"Conserved oncogenic behavior of the FAM83 family regulates MAPK signaling in human cancer","volume":"12","author":"Cipriano","year":"2014","unstructured":"Cipriano RMiskimen KLSBryson BLFoy CRBartel CA & Jackson MW2014Conserved oncogenic behavior of the FAM83 family regulates MAPK signaling in human cancer. Molecular Cancer Research121156\u20131165. (https:\/\/doi.org\/10.1158\/1541-7786.MCR-13-0289)"},{"key":"bib21","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"1261","article-title":"Familial growth hormone deficiency: a model of dominant and recessive mutations affecting a monomeric protein","volume":"79","author":"Cogan","year":"1994","unstructured":"Cogan JDPhillips JASchenkman SSMilner RD & Sakati N1994Familial growth hormone deficiency: a model of dominant and recessive mutations affecting a monomeric protein. Journal of Clinical Endocrinology and Metabolism791261\u20131265. (https:\/\/doi.org\/10.1210\/jcem.79.5.7962317)"},{"key":"bib22","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"3591","article-title":"A recurring dominant negative mutation causes autosomal dominant growth hormone deficiency\u2013a clinical research center study","volume":"80","author":"Cogan","year":"1995","unstructured":"Cogan JDRamel BLehto MPhillips JPrince MBlizzard RMde Ravel TJBrammert M & Groop L1995A recurring dominant negative mutation causes autosomal dominant growth hormone deficiency\u2013a clinical research center study. Journal of Clinical Endocrinology and Metabolism803591\u20133595. (https:\/\/doi.org\/10.1210\/jcem.80.12.8530604)"},{"key":"bib23","series-title":"Arquivos Brasileiros de Endocrinologia e Metabologia","first-page":"963","article-title":"Prostate cancer and acromegaly","volume":"53","author":"Correa","year":"2009","unstructured":"Correa LLLima GABde Melo Paiva HBSilva CMDSCavallieri SAMiranda LCD & Gadelha MR2009Prostate cancer and acromegaly. Arquivos Brasileiros de Endocrinologia e Metabologia53963\u2013968. (https:\/\/doi.org\/10.1590\/s0004-27302009000800009)"},{"key":"bib24","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"2182","article-title":"Cancer incidence in patients with acromegaly: a cohort study and meta-analysis of the literature","volume":"103","author":"Dal","year":"2018","unstructured":"Dal JLeisner MZHermansen KFarkas DKBengtsen MKistorp CNielsen EHAndersen MFeldt-Rasmussen UDekkers OM, 2018Cancer incidence in patients with acromegaly: a cohort study and meta-analysis of the literature. Journal of Clinical Endocrinology and Metabolism1032182\u20132188. (https:\/\/doi.org\/10.1210\/jc.2017-02457)"},{"key":"bib25","series-title":"Clinical Diabetes and Endocrinology","first-page":"24","article-title":"Acromegaly and thyroid cancer: analysis of evolution in a series of patients","volume":"6","author":"Danilowicz","year":"2020","unstructured":"Danilowicz KSosa SGonzalez Pernas MSBamberger EDiez SMFainstein-Day PFurioso AGlerean MGuitelman MKatz D, 2020Acromegaly and thyroid cancer: analysis of evolution in a series of patients. Clinical Diabetes and Endocrinology624. (https:\/\/doi.org\/10.1186\/s40842-020-00113-4)"},{"key":"bib26","series-title":"Paediatrics and Child Health","first-page":"285","article-title":"A review of growth hormone deficiency","volume":"29","author":"Dattani","year":"2019","unstructured":"Dattani MT & Malhotra N2019A review of growth hormone deficiency. Paediatrics and Child Health29285\u2013292. (https:\/\/doi.org\/10.1016\/j.paed.2019.04.001)"},{"key":"bib27","series-title":"Frontiers in Endocrinology","first-page":"35","article-title":"The growth hormone receptor: mechanism of receptor activation, cell signaling, and physiological aspects","volume":"9","author":"Dehkhoda","year":"2018","unstructured":"Dehkhoda FLee CMMMedina J & Brooks AJ2018The growth hormone receptor: mechanism of receptor activation, cell signaling, and physiological aspects. Frontiers in Endocrinology935. (https:\/\/doi.org\/10.3389\/fendo.2018.00035)"},{"key":"bib28","series-title":"Current Opinion in Genetics and Development","first-page":"31","article-title":"New insight into BRAF mutations in cancer","volume":"17","author":"Dhomen","year":"2007","unstructured":"Dhomen N & Marais R2007New insight into BRAF mutations in cancer. Current Opinion in Genetics and Development1731\u201339. (https:\/\/doi.org\/10.1016\/j.gde.2006.12.005)"},{"key":"bib29","series-title":"EMBO Journal","first-page":"1091","article-title":"Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival","volume":"29","author":"Drosten","year":"2010","unstructured":"Drosten MDhawahir ASum EYMUrosevic JLechuga CGEsteban LMCastellano EGuerra CSantos E & Barbacid M2010Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival. EMBO Journal291091\u20131104. (https:\/\/doi.org\/10.1038\/emboj.2010.7)"},{"key":"bib30","series-title":"FEBS Letters","first-page":"165","article-title":"An exon-skipping mutation in the btk gene of a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency","volume":"346","author":"Duriez","year":"1994","unstructured":"Duriez BDuquesnoy PDastot FBougn\u00e8res PAmselem S & Goossens M1994An exon-skipping mutation in the btk gene of a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency. FEBS Letters346165\u2013170. (https:\/\/doi.org\/10.1016\/0014-5793(9400457-9)"},{"key":"bib31","series-title":"Frontiers in Endocrinology","first-page":"390","article-title":"Colonic cancer and acromegaly","volume":"10","author":"Dworakowska","year":"2019","unstructured":"Dworakowska D & Grossman AB2019Colonic cancer and acromegaly. Frontiers in Endocrinology10390. (https:\/\/doi.org\/10.3389\/fendo.2019.00390)"},{"key":"bib32","series-title":"Disease Models and Mechanisms","first-page":"649","article-title":"Unbound (bioavailable) IGF1 enhances somatic growth","volume":"4","author":"Elis","year":"2011","unstructured":"Elis SWu YCourtland HWCannata DSun HBeth-On MLiu CJasper HDomen\u00e9 HKarabatas L, 2011Unbound (bioavailable) IGF1 enhances somatic growth. Disease Models and Mechanisms4649\u2013658. (https:\/\/doi.org\/10.1242\/dmm.006775)"},{"key":"bib33","series-title":"Lancet Oncology","first-page":"322","article-title":"The MAPK signaling pathways and colorectal cancer","volume":"6","author":"Fang","year":"2005","unstructured":"Fang JY & Richardson BC2005The MAPK signaling pathways and colorectal cancer. Lancet Oncology6322\u2013327. (https:\/\/doi.org\/10.1016\/S1470-2045(0570168-6)"},{"key":"bib34","series-title":"Clinical Endocrinology","first-page":"408","article-title":"HESX1 mutations in patients with congenital hypopituitarism: variable phenotypes with the same genotype","volume":"85","author":"Fang","year":"2016","unstructured":"Fang QBenedetti AFFMa QGregory LLi JZDattani MSadeghi-Nejad AArnhold IJPMendonca BBCamper SA, 2016HESX1 mutations in patients with congenital hypopituitarism: variable phenotypes with the same genotype. Clinical Endocrinology85408\u2013414. (https:\/\/doi.org\/10.1111\/cen.13067)"},{"key":"bib35","series-title":"Trends in Cell Biology","first-page":"427","article-title":"The regulation of energy metabolism and the IGF-1\/mTOR pathways by the p53 protein","volume":"20","author":"Feng","year":"2010","unstructured":"Feng Z & Levine AJ2010The regulation of energy metabolism and the IGF-1\/mTOR pathways by the p53 protein. Trends in Cell Biology20427\u2013434. (https:\/\/doi.org\/10.1016\/j.tcb.2010.03.004)"},{"key":"bib36","series-title":"Cancer Treatment Reviews","first-page":"193","article-title":"PI3K\/Akt signalling pathway and cancer","volume":"30","author":"Fresno Vara","year":"2004","unstructured":"Fresno Vara JACasado Ede Castro JCejas PBelda-Iniesta C & Gonz\u00e1lez-Bar\u00f3n M2004PI3K\/Akt signalling pathway and cancer. Cancer Treatment Reviews30193\u2013204. (https:\/\/doi.org\/10.1016\/j.ctrv.2003.07.007)"},{"key":"bib37","series-title":"Genes","article-title":"Regulation of mTORC2 signaling","volume":"11","author":"Fu","year":"2020","unstructured":"Fu W & Hall MN2020Regulation of mTORC2 signaling. Genes11. (https:\/\/doi.org\/10.3390\/genes11091045)"},{"key":"bib38","series-title":"Cell Metabolism","first-page":"355","article-title":"Is growth hormone resistance\/IGF-1 reduction good for you?","volume":"13","author":"Gallagher","year":"2011","unstructured":"Gallagher EJ & LeRoith D2011Is growth hormone resistance\/IGF-1 reduction good for you?Cell Metabolism13355\u2013356. (https:\/\/doi.org\/10.1016\/j.cmet.2011.03.003)"},{"key":"bib39","series-title":"Pediatric Research","first-page":"654","article-title":"Isolated growth hormone deficiency type IA associated with a 45-kilobase gene deletion within the human growth hormone gene cluster in an Italian family","volume":"36","author":"Ghizzoni","year":"1994","unstructured":"Ghizzoni LDuquesnoy PTorresani TVottero AGoossens M & Bernasconi S1994Isolated growth hormone deficiency type IA associated with a 45-kilobase gene deletion within the human growth hormone gene cluster in an Italian family. Pediatric Research36654\u2013659. (https:\/\/doi.org\/10.1203\/00006450-199411000-00021)"},{"key":"bib40","series-title":"European Journal of Endocrinology","first-page":"629","article-title":"Insulin-like growth factor ternary complex components as biomarkers for the diagnosis of short stature","volume":"185","author":"Giannakopoulos","year":"2021","unstructured":"Giannakopoulos AEfthymiadou A & Chrysis D2021Insulin-like growth factor ternary complex components as biomarkers for the diagnosis of short stature. European Journal of Endocrinology185629\u2013635. (https:\/\/doi.org\/10.1530\/EJE-21-0475)"},{"key":"bib41","series-title":"Journal of Endocrinological Investigation","first-page":"1017","article-title":"Use of Pegvisomant in acromegaly. An Italian Society of Endocrinology guideline","volume":"37","author":"Giustina","year":"2014","unstructured":"Giustina AAmbrosio MRBeck Peccoz PBogazzi FCannavo SDe Marinis LDe Menis EGrottoli S & Pivonello R2014Use of Pegvisomant in acromegaly. An Italian Society of Endocrinology guideline. Journal of Endocrinological Investigation371017\u20131030. (https:\/\/doi.org\/10.1007\/s40618-014-0146-x)"},{"key":"bib42","series-title":"Reviews in Endocrine and Metabolic Disorders","first-page":"667","article-title":"Multidisciplinary management of acromegaly: a consensus","volume":"21","author":"Giustina","year":"2020","unstructured":"Giustina ABarkhoudarian GBeckers ABen-Shlomo ABiermasz NBiller BBoguszewski CBolanowski MBollerslev JBonert V, 2020Multidisciplinary management of acromegaly: a consensus. Reviews in Endocrine and Metabolic Disorders21667\u2013678. (https:\/\/doi.org\/10.1007\/s11154-020-09588-z)"},{"key":"bib43","series-title":"Endocrine-Related Cancer","first-page":"481","article-title":"Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo","volume":"17","author":"Gu","year":"2010","unstructured":"Gu LVogiatzi PPuhr MDagvadorj ALutz JRyder AAddya SFortina PCooper CLeiby B, 2010Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo. Endocrine-Related Cancer17481\u2013493. (https:\/\/doi.org\/10.1677\/ERC-09-0328)"},{"key":"bib44","series-title":"Cancer Cell","first-page":"9","article-title":"Defining the role of mTOR in cancer","volume":"12","author":"Guertin","year":"2007","unstructured":"Guertin DA & Sabatini DM2007Defining the role of mTOR in cancer. Cancer Cell129\u201322. (https:\/\/doi.org\/10.1016\/j.ccr.2007.05.008)"},{"key":"bib45","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"417","article-title":"Growth hormone receptor deficiency in Ecuador: clinical and biochemical phenotype in two populations","volume":"76","author":"Guevara-Aguirre","year":"1993","unstructured":"Guevara-Aguirre JRosenbloom ALFielder PJDiamond FB & Rosenfeld RG1993Growth hormone receptor deficiency in Ecuador: clinical and biochemical phenotype in two populations. Journal of Clinical Endocrinology and Metabolism76417\u2013423. (https:\/\/doi.org\/10.1210\/jcem.76.2.7679400)"},{"key":"bib46","series-title":"Hormone Research, Supplement","first-page":"175","article-title":"Low serum levels of IGF-I, BP3 and ALS are associated to severe short stature, obesity, premature aging, increased cardiovascular mortality and absence of cancer in the Ecuadorian cohort of Laron syndrome subjects","volume":"1","author":"Guevara-Aguirre","year":"2007","unstructured":"Guevara-Aguirre JGuevara-Aguirre MSaavedra J & Bernstein G2007Low serum levels of IGF-I, BP3 and ALS are associated to severe short stature, obesity, premature aging, increased cardiovascular mortality and absence of cancer in the Ecuadorian cohort of Laron syndrome subjects. Hormone Research, Supplement1175."},{"key":"bib47","series-title":"Science Translational Medicine","first-page":"70ra13","article-title":"Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans","volume":"3","author":"Guevara-Aguirre","year":"2011","unstructured":"Guevara-Aguirre JBalasubramanian PGuevara-Aguirre MWei MMadia FCheng CWHwang DMartin-Montalvo ASaavedra JIngles S, 2011Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Science Translational Medicine370ra13. (https:\/\/doi.org\/10.1126\/scitranslmed.3001845)"},{"key":"bib48","series-title":"Diabetologia","first-page":"37","article-title":"Obesity, diabetes and cancer: insight into the relationship from a cohort with growth hormone receptor deficiency","volume":"58","author":"Guevara-Aguirre","year":"2015","unstructured":"Guevara-Aguirre J & Rosenbloom AL2015Obesity, diabetes and cancer: insight into the relationship from a cohort with growth hormone receptor deficiency. Diabetologia5837\u201342. (https:\/\/doi.org\/10.1007\/s00125-014-3397-3)"},{"key":"bib49","series-title":"Reviews in Endocrine and Metabolic Disorders","first-page":"59","article-title":"Insights from the clinical phenotype of subjects with Laron syndrome in Ecuador","volume":"22","author":"Guevara-Aguirre","year":"2021","unstructured":"Guevara-Aguirre JBautista CTorres CPe\u00f1a GGuevara CPalacios CGuevara A & Gavilanes AWD2021Insights from the clinical phenotype of subjects with Laron syndrome in Ecuador. Reviews in Endocrine and Metabolic Disorders2259\u201370. (https:\/\/doi.org\/10.1007\/s11154-020-09602-4)"},{"key":"bib50","series-title":"Cell Metabolism","first-page":"725","article-title":"Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c","volume":"15","author":"Hagiwara","year":"2012","unstructured":"Hagiwara ACornu MCybulski NPolak PBetz CTrapani FTerracciano LHeim MHR\u00fcegg MA & Hall MN2012Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Cell Metabolism15725\u2013738. (https:\/\/doi.org\/10.1016\/j.cmet.2012.03.015)"},{"key":"bib51","series-title":"Journal of Molecular Endocrinology","first-page":"T69","article-title":"IGF1 receptor signaling pathways","volume":"61","author":"Hakuno","year":"2018","unstructured":"Hakuno F & Takahashi SI2018IGF1 receptor signaling pathways. Journal of Molecular Endocrinology61T69\u2013T86. (https:\/\/doi.org\/10.1530\/JME-17-0311)"},{"key":"bib52","series-title":"Growth Hormone and IGF Research","first-page":"37","article-title":"Genetics of gigantism and acromegaly","volume":"30\u201331","author":"Hannah-Shmouni","year":"2016","unstructured":"Hannah-Shmouni FTrivellin G & Stratakis CA2016Genetics of gigantism and acromegaly. Growth Hormone and IGF Research30\u20133137\u201341. (https:\/\/doi.org\/10.1016\/j.ghir.2016.08.002)"},{"key":"bib53","series-title":"Journal of Biomedicine and Biotechnology","first-page":"150960","article-title":"Clinical relevance of KRAS in human cancers","volume":"2010","author":"Janc\u00edk","year":"2010","unstructured":"Janc\u00edk SDr\u00e1bek JRadzioch D & Hajd\u00fach M2010Clinical relevance of KRAS in human cancers. Journal of Biomedicine and Biotechnology2010150960. (https:\/\/doi.org\/10.1155\/2010\/150960)"},{"key":"bib54","series-title":"Molecular and Cellular Biology","first-page":"4504","article-title":"Cellular transformation and malignancy induced by ras require c-Jun","volume":"16","author":"Johnson","year":"1996","unstructured":"Johnson RSpiegelman BHanahan D & Wisdom R1996Cellular transformation and malignancy induced by ras require c-Jun. Molecular and Cellular Biology164504\u20134511. (https:\/\/doi.org\/10.1128\/MCB.16.8.4504)"},{"key":"bib55","series-title":"Journal of Applied Pharmaceutical Science","first-page":"31","article-title":"Synergistic effect of paclitaxel and curcumin in nano-formulations on U87 and A549 cancer cell lines","volume":"12","author":"Joyceline","year":"2022","unstructured":"Joyceline PSushruta S & Bharath Raja G2022Synergistic effect of paclitaxel and curcumin in nano-formulations on U87 and A549 cancer cell lines. Journal of Applied Pharmaceutical Science1231\u201347. (https:\/\/doi.org\/10.7324\/JAPS.2021.120204)"},{"key":"bib56","series-title":"Nature Reviews. Endocrinology","first-page":"366","article-title":"The GH\/IGF-1 axis in ageing and longevity","volume":"9","author":"Junnila","year":"2013","unstructured":"Junnila RKList EOBerryman DEMurrey JW & Kopchick JJ2013The GH\/IGF-1 axis in ageing and longevity. Nature Reviews. Endocrinology9366\u2013376. (https:\/\/doi.org\/10.1038\/nrendo.2013.67)"},{"key":"bib57","series-title":"Frontiers in Endocrinology","first-page":"924952","article-title":"Acromegaly and colorectal neoplasm: an update","volume":"13","author":"Kasuki","year":"2022","unstructured":"Kasuki LMaia B & Gadelha MR2022Acromegaly and colorectal neoplasm: an update. Frontiers in Endocrinology13924952. (https:\/\/doi.org\/10.3389\/fendo.2022.924952)"},{"key":"bib58","series-title":"eLife","first-page":"e03772","article-title":"How IGF-1 activates its receptor","volume":"3","author":"Kavran","year":"2014","unstructured":"Kavran JMMcCabe JMByrne POConnacher MKWang ZRamek ASarabipour SShan YShaw DEHristova K, 2014How IGF-1 activates its receptor. eLife3e03772. (https:\/\/doi.org\/10.7554\/eLife.03772)"},{"key":"bib59","series-title":"International Journal of Molecular Sciences","article-title":"Growth hormone deficiency following traumatic brain injury","volume":"20","author":"Kgosidialwa","year":"2019","unstructured":"Kgosidialwa OHakami OMuhammad Zia-Ul-Hussnain H & Agha A2019Growth hormone deficiency following traumatic brain injury. International Journal of Molecular Sciences20. (https:\/\/doi.org\/10.3390\/ijms20133323)"},{"key":"bib60","series-title":"International Journal of Oncology","first-page":"413","article-title":"Mutations of ras genes in human tumors (review)","volume":"7","author":"Kiaris","year":"1995","unstructured":"Kiaris H & Spandidos DA1995Mutations of ras genes in human tumors (review). International Journal of Oncology7413\u2013421. (https:\/\/doi.org\/10.3892\/ijo.7.3.413)"},{"key":"bib61","series-title":"Nature Communications","first-page":"4434","article-title":"Structural basis for assembly and disassembly of the IGF\/IGFBP\/ALS ternary complex","volume":"13","author":"Kim","year":"2022a","unstructured":"Kim HFu YHong HJLee SGLee DS & Kim HM2022aStructural basis for assembly and disassembly of the IGF\/IGFBP\/ALS ternary complex. Nature Communications134434. (https:\/\/doi.org\/10.1038\/s41467-022-32214-2)"},{"key":"bib62","series-title":"International Journal of Molecular Sciences","article-title":"Transcription factors as targets of natural compounds in age-related diseases and cancer: potential therapeutic applications","volume":"23","author":"Kim","year":"2022b","unstructured":"Kim MEKim DH & Lee JS2022bTranscription factors as targets of natural compounds in age-related diseases and cancer: potential therapeutic applications. International Journal of Molecular Sciences23. (https:\/\/doi.org\/10.3390\/ijms232213882)"},{"key":"bib63","series-title":"Gastric Cancer","first-page":"33","article-title":"Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study","volume":"25","author":"Kim","year":"2022c","unstructured":"Kim YMKim JHPark JSBaik SJChun JYoun YH & Park H2022cAssociation between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study. Gastric Cancer2533\u201341. (https:\/\/doi.org\/10.1007\/s10120-021-01222-4)"},{"key":"bib64","series-title":"Endocrine-Related Cancer","first-page":"399","article-title":"Identification of signaling pathways associated with cancer protection in Laron syndrome","volume":"23","author":"Lapkina-Gendler","year":"2016","unstructured":"Lapkina-Gendler LRotem IPasmanik-Chor MGurwitz DSarfstein RLaron Z & Werner H2016Identification of signaling pathways associated with cancer protection in Laron syndrome. Endocrine-Related Cancer23399\u2013410. (https:\/\/doi.org\/10.1530\/ERC-16-0054)"},{"issue":"1_Suppl","key":"bib65","series-title":"Acta Endocrinologica","first-page":"S18","article-title":"The syndrome of pituitary dwarfism with high serum concentration of growth hormone","volume":"56","author":"Laron","year":"1967","unstructured":"Laron Z & Pertzelan A1967The syndrome of pituitary dwarfism with high serum concentration of growth hormone. Acta Endocrinologica56(1_Suppl) S18. (https:\/\/doi.org\/10.1530\/acta.0.056S018)"},{"key":"bib66","series-title":"Mutation Research. Reviews in Mutation Research","first-page":"123","article-title":"IGF-I deficiency, longevity and cancer protection of patients with Laron syndrome","volume":"772","author":"Laron","year":"2017","unstructured":"Laron ZKauli RLapkina L & Werner H2017IGF-I deficiency, longevity and cancer protection of patients with Laron syndrome. Mutation Research. Reviews in Mutation Research772123\u2013133. (https:\/\/doi.org\/10.1016\/j.mrrev.2016.08.002)"},{"key":"bib67","series-title":"Current Opinion in Pharmacology","first-page":"136","article-title":"Nutrient weight against sarcopenia: regulation of the IGF-1\/PI3K\/Akt\/FOXO pathway in quinoa metabolites","volume":"61","author":"Liu","year":"2021","unstructured":"Liu PJHu YSWang MJ & Kang L2021Nutrient weight against sarcopenia: regulation of the IGF-1\/PI3K\/Akt\/FOXO pathway in quinoa metabolites. Current Opinion in Pharmacology61136\u2013141. (https:\/\/doi.org\/10.1016\/j.coph.2021.10.001)"},{"key":"bib68","series-title":"Reviews in Endocrine and Metabolic Disorders","first-page":"41","article-title":"Acromegaly: re-thinking the cancer risk","volume":"9","author":"Loeper","year":"2008","unstructured":"Loeper S & Ezzat S2008Acromegaly: re-thinking the cancer risk. Reviews in Endocrine and Metabolic Disorders941\u201358. (https:\/\/doi.org\/10.1007\/s11154-007-9063-z)"},{"key":"bib69","series-title":"Science","first-page":"1342","article-title":"Evolutionary medicine: from dwarf model systems to healthy centenarians?","volume":"299","author":"Longo","year":"2003","unstructured":"Longo VD & Finch CE2003Evolutionary medicine: from dwarf model systems to healthy centenarians?Science2991342\u20131346. (https:\/\/doi.org\/10.1126\/science.1077991)"},{"key":"bib70","series-title":"Trends in Pharmacological Sciences","first-page":"89","article-title":"Calorie restriction and cancer prevention: metabolic and molecular mechanisms","volume":"31","author":"Longo","year":"2010","unstructured":"Longo VD & Fontana L2010Calorie restriction and cancer prevention: metabolic and molecular mechanisms. Trends in Pharmacological Sciences3189\u201398. (https:\/\/doi.org\/10.1016\/j.tips.2009.11.004)"},{"key":"bib71","series-title":"Cancer Cell","first-page":"339","article-title":"Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis","volume":"1","author":"Lopez","year":"2002","unstructured":"Lopez T & Hanahan D2002Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis. Cancer Cell1339\u2013353. (https:\/\/doi.org\/10.1016\/s1535-6108(0200055-7)"},{"key":"bib72","series-title":"Journal of Surgical Research","first-page":"90","article-title":"IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1\/PI3K\/Akt signaling pathway in pancreatic cancer cells","volume":"160","author":"Ma","year":"2010","unstructured":"Ma JSawai HMatsuo YOchi NYasuda ATakahashi HWakasugi TFunahashi HSato M & Takeyama H2010IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1\/PI3K\/Akt signaling pathway in pancreatic cancer cells. Journal of Surgical Research16090\u2013101. (https:\/\/doi.org\/10.1016\/j.jss.2008.08.016)"},{"key":"bib73","series-title":"Gene","first-page":"282","article-title":"A novel heterozygous SOX2 mutation causing congenital bilateral anophthalmia, hypogonadotropic hypogonadism and growth hormone deficiency","volume":"534","author":"Macchiaroli","year":"2014","unstructured":"Macchiaroli AKelberman DAuriemma RSDrury SIslam LGiangiobbe SIroni GLench NSowden JCColao A, 2014A novel heterozygous SOX2 mutation causing congenital bilateral anophthalmia, hypogonadotropic hypogonadism and growth hormone deficiency. Gene534282\u2013285. (https:\/\/doi.org\/10.1016\/j.gene.2013.10.043)"},{"key":"bib74","series-title":"Growth Hormone and IGF Research","first-page":"71","article-title":"Occurrence of neoplasms in individuals with congenital, severe GH deficiency from the Itabaianinha kindred","volume":"41","author":"Marinho","year":"2018","unstructured":"Marinho CGMermejo LMSalvatori RAssirati JAOliveira CRPSantos EGLeal \u00c2CGBBarros-Oliveira CSDamascena NPLima CA, 2018Occurrence of neoplasms in individuals with congenital, severe GH deficiency from the Itabaianinha kindred. Growth Hormone and IGF Research4171\u201374. (https:\/\/doi.org\/10.1016\/j.ghir.2018.03.004)"},{"key":"bib75","series-title":"Recent Progress in Hormone Research","first-page":"35","article-title":"Growth hormone-releasing hormone: synthesis and signaling","volume":"50","author":"Mayo","year":"1995","unstructured":"Mayo KEGodfrey PASuhr STKulik DJ & Rahal JO1995Growth hormone-releasing hormone: synthesis and signaling. Recent Progress in Hormone Research5035\u201373. (https:\/\/doi.org\/10.1016\/b978-0-12-571150-0.50007-x)"},{"key":"bib76","series-title":"Nature Reviews. Endocrinology","first-page":"552","article-title":"A Consensus Statement on acromegaly therapeutic outcomes","volume":"14","author":"Melmed","year":"2018","unstructured":"Melmed SBronstein MDChanson PKlibanski ACasanueva FFWass JAHStrasburger CJLuger AClemmons DR & Giustina A2018A Consensus Statement on acromegaly therapeutic outcomes. Nature Reviews. Endocrinology14552\u2013561. (https:\/\/doi.org\/10.1038\/s41574-018-0058-5)"},{"key":"bib77","series-title":"Journal of Clinical Oncology","first-page":"4776","article-title":"Growth hormone secretion after conformal radiation therapy in pediatric patients with localized brain tumors","volume":"29","author":"Merchant","year":"2011","unstructured":"Merchant TERose SRBosley CWu SXiong X & Lustig RH2011Growth hormone secretion after conformal radiation therapy in pediatric patients with localized brain tumors. Journal of Clinical Oncology294776\u20134780. (https:\/\/doi.org\/10.1200\/JCO.2011.37.9453)"},{"key":"bib78","series-title":"Cancer","first-page":"100","article-title":"Occurrence of cancer in acromegaly and in hypopituitarism","volume":"10","author":"Mustacchi","year":"1957","unstructured":"Mustacchi P & Shimkin MB1957Occurrence of cancer in acromegaly and in hypopituitarism. Cancer10100\u2013104. (https:\/\/doi.org\/10.1002\/1097-0142(195701\/02)10:1<100::AID-CNCR2820100113>3.0.CO;2-V)"},{"key":"bib79","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"553","article-title":"Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans","volume":"84","author":"Olivecrona","year":"1999","unstructured":"Olivecrona HHilding AEkstr\u00f6m CBarle HNyberg BM\u00f6ller CDelhanty PJBaxter RCAngelin BEkstr\u00f6m TJ, 1999Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans. Journal of Clinical Endocrinology and Metabolism84553\u2013560. (https:\/\/doi.org\/10.1210\/jcem.84.2.5466)"},{"key":"bib80","series-title":"Cancer Management and Research","first-page":"2405","article-title":"The role of clusterin in cancer metastasis","volume":"11","year":"2019","unstructured":"Peng M, Deng J, Zhou S, Tao T, Su Q, Yang X & Yang X2019The role of clusterin in cancer metastasis. Cancer Management and Research112405\u20132414. (https:\/\/doi.org\/10.2147\/CMAR.S196273)"},{"key":"bib81","series-title":"Current Opinion in Endocrinology, Diabetes, and Obesity","first-page":"307","article-title":"Growth hormone and cancer: an update on progress","volume":"20","author":"Perry","year":"2013","unstructured":"Perry JKLiu DXWu ZSZhu T & Lobie PE2013Growth hormone and cancer: an update on progress. Current Opinion in Endocrinology, Diabetes, and Obesity20307\u2013313. (https:\/\/doi.org\/10.1097\/MED.0b013e328363183a)"},{"key":"bib82","series-title":"Trends in Endocrinology and Metabolism","first-page":"587","article-title":"Tumour-derived human growth hormone as a therapeutic target in oncology","volume":"28","author":"Perry","year":"2017","unstructured":"Perry JKWu ZSMertani HCZhu T & Lobie PE2017Tumour-derived human growth hormone as a therapeutic target in oncology. Trends in Endocrinology and Metabolism28587\u2013596. (https:\/\/doi.org\/10.1016\/j.tem.2017.05.003)"},{"key":"bib83","series-title":"Endocrine-Related Cancer","first-page":"505","article-title":"Acromegaly at diagnosis in 3173 patients from the Li\u00e8ge Acromegaly Survey (LAS) Database","volume":"24","author":"Petrossians","year":"2017","unstructured":"Petrossians PDaly AFNatchev EMaione LBlijdorp KSahnoun-Fathallah MAuriemma RDiallo AMHulting ALFerone D, 2017Acromegaly at diagnosis in 3173 patients from the Li\u00e8ge Acromegaly Survey (LAS) Database. Endocrine-Related Cancer24505\u2013518. (https:\/\/doi.org\/10.1530\/ERC-17-0253)"},{"key":"bib84","series-title":"Nature Reviews. Cancer","first-page":"159","article-title":"The insulin and insulin-like growth factor receptor family in neoplasia: an update","volume":"12","author":"Pollak","year":"2012","unstructured":"Pollak M2012The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nature Reviews. Cancer12159\u2013169. (https:\/\/doi.org\/10.1038\/nrc3215)"},{"key":"bib85","series-title":"Cancer Research","first-page":"2969","article-title":"The frequency of Ras mutations in cancer","volume":"80","author":"Prior","year":"2020","unstructured":"Prior IAHood FE & Hartley JL2020The frequency of Ras mutations in cancer. Cancer Research802969\u20132974. (https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-3682)"},{"key":"bib86","series-title":"BMC Endocrine Disorders","first-page":"17","article-title":"Two novel LHX3 mutations in patients with combined pituitary hormone deficiency including cervical rigidity and sensorineural hearing loss","volume":"17","author":"Ramzan","year":"2017","unstructured":"Ramzan KBin-Abbas BAl-Jomaa LAllam RAl-Owain M & Imtiaz F2017Two novel LHX3 mutations in patients with combined pituitary hormone deficiency including cervical rigidity and sensorineural hearing loss. BMC Endocrine Disorders1717. (https:\/\/doi.org\/10.1186\/s12902-017-0164-8)"},{"key":"bib87","series-title":"Endocrine Reviews","first-page":"369","article-title":"Growth hormone (GH) insensitivity due to primary GH receptor deficiency","volume":"15","author":"Rosenfeld","year":"1994","unstructured":"Rosenfeld RGRosenbloom AL & Guevara-Aguirre J1994Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocrine Reviews15369\u2013390. (https:\/\/doi.org\/10.1210\/edrv-15-3-369)"},{"key":"bib88","series-title":"Trends in Endocrinology and Metabolism","first-page":"186","article-title":"Mapping the growth hormone--Stat5b--IGF-I transcriptional circuit","volume":"23","author":"Rotwein","year":"2012","unstructured":"Rotwein P2012Mapping the growth hormone--Stat5b--IGF-I transcriptional circuit. Trends in Endocrinology and Metabolism23186\u2013193. (https:\/\/doi.org\/10.1016\/j.tem.2012.01.001)"},{"key":"bib89","series-title":"International Journal of Molecular Sciences","article-title":"Correlation between oxidative stress, nutrition, and cancer initiation","volume":"18","author":"Saha","year":"2017","unstructured":"Saha SKLee SBWon JChoi HYKim KYang GMDayem AA & Cho SG2017Correlation between oxidative stress, nutrition, and cancer initiation. International Journal of Molecular Sciences18. (https:\/\/doi.org\/10.3390\/ijms18071544)"},{"key":"bib90","series-title":"Endocrine Reviews","first-page":"20","article-title":"The role of the IGF system in cancer growth and metastasis: overview and recent insights","volume":"28","author":"Samani","year":"2007","unstructured":"Samani AAYakar SLeRoith D & Brodt P2007The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocrine Reviews2820\u201347. (https:\/\/doi.org\/10.1210\/er.2006-0001)"},{"key":"bib91","series-title":"Developmental Cell","first-page":"379","article-title":"Hyperinsulinemia drives epithelial tumorigenesis by abrogating cell competition","volume":"53","author":"Sanaki","year":"2020","unstructured":"Sanaki YNagata RKizawa DLeopold P & Igaki T2020Hyperinsulinemia drives epithelial tumorigenesis by abrogating cell competition. Developmental Cell53379\u2013389.e5. (https:\/\/doi.org\/10.1016\/j.devcel.2020.04.008)"},{"key":"bib92","series-title":"Science","first-page":"1496","article-title":"The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1","volume":"320","author":"Sancak","year":"2008","unstructured":"Sancak YPeterson TRShaul YDLindquist RAThoreen CCBar-Peled L & Sabatini DM2008The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science3201496\u20131501. (https:\/\/doi.org\/10.1126\/science.1157535)"},{"key":"bib93","series-title":"Skeletal Muscle","first-page":"4","article-title":"Regulation of skeletal muscle growth by the IGF1-Akt\/PKB pathway: insights from genetic models","volume":"1","author":"Schiaffino","year":"2011","unstructured":"Schiaffino S & Mammucari C2011Regulation of skeletal muscle growth by the IGF1-Akt\/PKB pathway: insights from genetic models. Skeletal Muscle14. (https:\/\/doi.org\/10.1186\/2044-5040-1-4)"},{"key":"bib94","series-title":"Growth Hormone and IGF Research","first-page":"54","article-title":"Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: a preliminary report","volume":"17","author":"Shevah","year":"2007","unstructured":"Shevah O & Laron Z2007Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: a preliminary report. Growth Hormone and IGF Research1754\u201357. (https:\/\/doi.org\/10.1016\/j.ghir.2006.10.007)"},{"key":"bib95","series-title":"European Journal of Endocrinology","first-page":"485","article-title":"Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies","volume":"164","author":"Steuerman","year":"2011","unstructured":"Steuerman RShevah O & Laron Z2011Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies. European Journal of Endocrinology164485\u2013489. (https:\/\/doi.org\/10.1530\/EJE-10-0859)"},{"key":"bib96","series-title":"Immunologic Research","first-page":"262","article-title":"X-linked hypogammaglobulinemia and isolated growth hormone deficiency: an update","volume":"40","author":"Stewart","year":"2008","unstructured":"Stewart DMTian LNotarangelo LD & Nelson DL2008X-linked hypogammaglobulinemia and isolated growth hormone deficiency: an update. Immunologic Research40262\u2013270. (https:\/\/doi.org\/10.1007\/s12026-007-0028-9)"},{"key":"bib97","series-title":"Proceedings of the National Academy of Sciences of the United States of America","first-page":"3438","article-title":"Functionally significant insulin-like growth factor I receptor mutations in centenarians","volume":"105","author":"Suh","year":"2008","unstructured":"Suh YAtzmon GCho MOHwang DLiu BLeahy DJBarzilai N & Cohen P2008Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proceedings of the National Academy of Sciences of the United States of America1053438\u20133442. (https:\/\/doi.org\/10.1073\/pnas.0705467105)"},{"key":"bib98","series-title":"Clinical Pediatric Endocrinology","first-page":"15","article-title":"Molecular and clinical findings in patients with LHX4 and OTX2 Mutations","volume":"22","author":"Tajima","year":"2013","unstructured":"Tajima TIshizu K & Nakamura A2013Molecular and clinical findings in patients with LHX4 and OTX2 Mutations. Clinical Pediatric Endocrinology2215\u201323. (https:\/\/doi.org\/10.1292\/cpe.22.15)"},{"key":"bib99","series-title":"Cytokine and Growth Factor Reviews","first-page":"67","article-title":"Crosstalk between insulin-like growth factor (IGF) receptor and integrins through direct integrin binding to IGF1","volume":"34","author":"Takada","year":"2017","unstructured":"Takada YTakada YK & Fujita M2017Crosstalk between insulin-like growth factor (IGF) receptor and integrins through direct integrin binding to IGF1. Cytokine and Growth Factor Reviews3467\u201372. (https:\/\/doi.org\/10.1016\/j.cytogfr.2017.01.003)"},{"key":"bib100","series-title":"Journal of Clinical Investigation","first-page":"1159","article-title":"Biologically inactive growth hormone caused by an amino acid substitution","volume":"100","author":"Takahashi","year":"1997","unstructured":"Takahashi YShirono HArisaka OTakahashi KYagi TKoga JKaji HOkimura YAbe HTanaka T, 1997Biologically inactive growth hormone caused by an amino acid substitution. Journal of Clinical Investigation1001159\u20131165. (https:\/\/doi.org\/10.1172\/JCI119627)"},{"issue":"Supplement B","key":"bib101","series-title":"Growth Hormone and IGF Research","first-page":"18","article-title":"PIT1 abnormality","volume":"9","author":"Tatsumi","year":"1999","unstructured":"Tatsumi K & Amino N1999PIT1 abnormality. Growth Hormone and IGF Research9(Supplement B) 18\u201322. (https:\/\/doi.org\/10.1016\/s1096-6374(9980076-8)"},{"key":"bib102","series-title":"European Journal of Endocrinology","first-page":"D1","article-title":"Thyroid and colorectal cancer screening in acromegaly patients: should it be different from that in the general population?","volume":"183","author":"Terzolo","year":"2020","unstructured":"Terzolo MPuglisi SReimondo GDimopoulou C & Stalla GK2020Thyroid and colorectal cancer screening in acromegaly patients: should it be different from that in the general population?European Journal of Endocrinology183D1\u2013D13. (https:\/\/doi.org\/10.1530\/EJE-19-1009)"},{"key":"bib103","series-title":"Deutsche Medizinische Wochenschrift","first-page":"380","article-title":"Theraphy of acromegaly -Data from the German acromegaly register","volume":"148","author":"Tonjes","year":"2023","unstructured":"Tonjes AQuinkler MKnappe UStormann SSchofl CSchopohl J & Meyhofer SM2023Theraphy of acromegaly -Data from the German acromegaly register. Deutsche Medizinische Wochenschrift148380\u2013385. (https:\/\/doi.org\/10.1055\/a-1847-2553)"},{"key":"bib104","series-title":"Oncogenesis","first-page":"e103","article-title":"Regulation of the pentose phosphate pathway by an androgen receptor-mTOR-mediated mechanism and its role in prostate cancer cell growth","volume":"3","author":"Tsouko","year":"2014","unstructured":"Tsouko EKhan ASWhite MAHan JJShi YMerchant FASharpe MAXin L & Frigo DE2014Regulation of the pentose phosphate pathway by an androgen receptor-mTOR-mediated mechanism and its role in prostate cancer cell growth. Oncogenesis3e103. (https:\/\/doi.org\/10.1038\/oncsis.2014.18)"},{"key":"bib105","series-title":"Endocrine Practice","first-page":"51","article-title":"The prevalence of cancer and its relation to disease activity in patients with acromegaly: two centers\u2019 experience","volume":"27","author":"Ucan","year":"2021","unstructured":"Ucan BKizilgul MKarci ACDuger HErkam Sencar MImga NNDemirci TBerker D & Cakal E2021The prevalence of cancer and its relation to disease activity in patients with acromegaly: two centers\u2019 experience. Endocrine Practice2751\u201355. (https:\/\/doi.org\/10.4158\/EP-2020-0398)"},{"key":"bib106","series-title":"Breast Cancer Research and Treatment","first-page":"233","article-title":"The GH1\/IGF-1 axis polymorphisms and their impact on breast cancer development","volume":"104","author":"Wagner","year":"2007","unstructured":"Wagner KHemminki K & F\u00f6rsti A2007The GH1\/IGF-1 axis polymorphisms and their impact on breast cancer development. Breast Cancer Research and Treatment104233\u2013248. (https:\/\/doi.org\/10.1007\/s10549-006-9411-9)"},{"key":"bib107","series-title":"Oncogene","first-page":"2703","article-title":"Tumor suppressors govern insulin-like growth factor signaling pathways: implications in metabolism and cancer","volume":"31","author":"Werner","year":"2012","unstructured":"Werner H2012Tumor suppressors govern insulin-like growth factor signaling pathways: implications in metabolism and cancer. Oncogene312703\u20132714. (https:\/\/doi.org\/10.1038\/onc.2011.447)"},{"key":"bib108","series-title":"Molecular Cancer","first-page":"28","article-title":"Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathway","volume":"17","author":"Werner","year":"2018","unstructured":"Werner HMeisel-Sharon S & Bruchim I2018Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathway. Molecular Cancer1728. (https:\/\/doi.org\/10.1186\/s12943-018-0807-z)"},{"key":"bib109","series-title":"Cells","article-title":"Genome-wide profiling of Laron syndrome patients identifies novel cancer protection pathways","volume":"8","author":"Werner","year":"2019","unstructured":"Werner HLapkina-Gendler LAchlaug LNagaraj KSomri LYaron-Saminsky DPasmanik-Chor MSarfstein RLaron Z & Yakar S2019Genome-wide profiling of Laron syndrome patients identifies novel cancer protection pathways. Cells8. (https:\/\/doi.org\/10.3390\/cells8060596)"},{"key":"bib110","series-title":"Molecular and Cellular Endocrinology","first-page":"111003","article-title":"Role of the GH-IGF1 system in progression of cancer","volume":"518","author":"Werner","year":"2020","unstructured":"Werner H & Laron Z2020Role of the GH-IGF1 system in progression of cancer. Molecular and Cellular Endocrinology518111003. (https:\/\/doi.org\/10.1016\/j.mce.2020.111003)"},{"key":"bib111","series-title":"Cells","article-title":"Laron syndrome research paves the way for new insights in oncological investigation","volume":"9","author":"Werner","year":"2020","unstructured":"Werner HSarfstein RNagaraj K & Laron Z2020Laron syndrome research paves the way for new insights in oncological investigation. Cells9. (https:\/\/doi.org\/10.3390\/cells9112446)"},{"key":"bib112","series-title":"American Journal of Physiology. Endocrinology and Metabolism","first-page":"E393","article-title":"In vivo regulation of growth hormone-stimulated gene transcription by STAT5b","volume":"286","author":"Woelfle","year":"2004","unstructured":"Woelfle J & Rotwein P2004In vivo regulation of growth hormone-stimulated gene transcription by STAT5b. American Journal of Physiology. Endocrinology and Metabolism286E393\u2013E401. (https:\/\/doi.org\/10.1152\/ajpendo.00389.2003)"},{"key":"bib113","series-title":"PLoS One","first-page":"e88787","article-title":"Risk of thyroid nodular disease and thyroid cancer in patients with acromegaly-meta-analysis and systematic review","volume":"9","author":"Wolinski","year":"2014","unstructured":"Wolinski KCzarnywojtek A & Ruchala M2014Risk of thyroid nodular disease and thyroid cancer in patients with acromegaly-meta-analysis and systematic review. PLoS One9e88787. (https:\/\/doi.org\/10.1371\/journal.pone.0088787)"},{"key":"bib114","series-title":"Endocrine-Related Cancer","first-page":"245","article-title":"BRAF mutation in thyroid cancer","volume":"12","author":"Xing","year":"2005","unstructured":"Xing M2005BRAF mutation in thyroid cancer. Endocrine-Related Cancer12245\u2013262. (https:\/\/doi.org\/10.1677\/erc.1.0978)"},{"key":"bib115","series-title":"Oncology Letters","first-page":"41","article-title":"Function of insulin-like growth factor 1 receptor in cancer resistance to chemotherapy","volume":"15","author":"Yuan","year":"2018","unstructured":"Yuan JYin ZTao KWang G & Gao J2018Function of insulin-like growth factor 1 receptor in cancer resistance to chemotherapy. Oncology Letters1541\u201347. (https:\/\/doi.org\/10.3892\/ol.2017.7276)"},{"key":"bib116","series-title":"Journal of Biomedicine and Translational Research","first-page":"69","article-title":"Elevated levels of serum glucose, triglyceride, and liver enzymes in a rat model of 7,12 dimethylbenz[a]anthracene (DMBA)-induced carcinogenesis","volume":"8","author":"Yustisia","year":"2022","unstructured":"Yustisia IPadlianah PArif M & Cangara MH2022Elevated levels of serum glucose, triglyceride, and liver enzymes in a rat model of 7,12 dimethylbenz[a]anthracene (DMBA)-induced carcinogenesis. Journal of Biomedicine and Translational Research869\u201375. (https:\/\/doi.org\/10.14710\/jbtr.v8i2.14268)"},{"key":"bib117","series-title":"Molecular Cancer","first-page":"87","article-title":"The role of the PI3K\/Akt\/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses","volume":"14","author":"Zhang","year":"2015","unstructured":"Zhang LWu JLing MTZhao L & Zhao KN2015The role of the PI3K\/Akt\/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses. Molecular Cancer1487. (https:\/\/doi.org\/10.1186\/s12943-015-0361-x)"},{"key":"bib118","series-title":"Nature Reviews. Molecular Cell Biology","first-page":"21","article-title":"mTOR: from growth signal integration to cancer, diabetes and ageing","volume":"12","author":"Zoncu","year":"2011","unstructured":"Zoncu REfeyan A & Sabatini DM2011mTOR: from growth signal integration to cancer, diabetes and ageing. Nature Reviews. Molecular Cell Biology1221\u201335. (https:\/\/doi.org\/10.1038\/nrm3025)"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/30\/10\/ERC-22-0402.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/30\/10\/ERC-22-0402.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/30\/10\/ERC-22-0402.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:56:29Z","timestamp":1784555789000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/erc\/article\/25702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,10]]},"references-count":118,"journal-issue":{"issue":"10"},"URL":"https:\/\/doi.org\/10.1530\/erc-22-0402","relation":{},"ISSN":["1351-0088","1479-6821"],"issn-type":[{"value":"1351-0088","type":"print"},{"value":"1479-6821","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,10]]}}}